Because the polyclonal antibody (but not the monoclonal antibody) recognizes cleaved galectin-3, we demonstrated that using a single antibody is not enough to provide the complete picture of the significance of this protein in cancer progression. This evidence concerns the gene LGALS3 and cancer.